{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:31:54Z","timestamp":1778603514980,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.transci.2023.103719","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T21:10:42Z","timestamp":1683061842000},"page":"103719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The implementation of automated red blood cell exchange (erythrocytapheresis) as a treatment modality in sickle cell disease patients: Single center experience"],"prefix":"10.1016","volume":"62","author":[{"given":"Fatma Soliman Elsayed","family":"Ebeid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9757","key":"10.1016\/j.transci.2023.103719_bib1","first-page":"2018","volume":"376","author":"Rees","year":"2010","journal-title":"Sick-Cell Dis Lancet"},{"issue":"7","key":"10.1016\/j.transci.2023.103719_bib2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1182\/blood-2015-09-618587","article-title":"Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease","volume":"127","author":"Hoban","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.transci.2023.103719_bib3","unstructured":"WHO: Sickle cell anaemia. Agenda item 11.4. In: 59th World Health Assembly, 27 May 2006. EB118.R1. Available from http:\/\/www.who.int\/gb\/ebwha\/pdf_files\/EBSS-EB118\u20132006-REC1\/english\/Res\/reseb118_2006_rec1-en.pdf."},{"key":"10.1016\/j.transci.2023.103719_bib4","unstructured":"UN General Assembly. Recognition of sickle cell anaemia as a public health problem; 2008 (A\/RES\/63\/237)."},{"key":"10.1016\/j.transci.2023.103719_bib5","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1182\/blood-2009-07-233700","article-title":"Improved survival of children and adolescents with sickle cell disease","volume":"115","author":"Quinn","year":"2010","journal-title":"Blood"},{"issue":"905\u2013912","key":"10.1016\/j.transci.2023.103719_bib6","first-page":"8","article-title":"Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London","volume":"92","author":"Telfer","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2023.103719_bib7","first-page":"269","article-title":"Factors associated with sickle cell disease mortality among hospitalized Angolan children and adolescents","volume":"26","author":"Van-Dunem","year":"2007","journal-title":"West Afr J Med"},{"issue":"2","key":"10.1016\/j.transci.2023.103719_bib8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/pbc.24175","article-title":"global perspective on sickle cell disease","volume":"59","author":"Aygun","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.transci.2023.103719_bib9","first-page":"1","article-title":"Hydroxyurea therapy for sickle cell anemia","author":"McGann","year":"2015","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"10.1016\/j.transci.2023.103719_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pcl.2008.02.003","article-title":"Hydroxyurea for children with sickle cell disease","volume":"55","author":"Heeney","year":"2008","journal-title":"Pedia Clin N. Am"},{"issue":"6","key":"10.1016\/j.transci.2023.103719_bib11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/phar.2405","article-title":"Systematic review of voxelotor: a first-in-class sickle hemoglobin polymerization inhibitor for management of sickle cell disease","volume":"40","author":"Han","year":"2020","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.transci.2023.103719_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/2040620713483063","article-title":"Hematopoietic stem-cell transplantation for sickle cell disease: current evidence and opinions","volume":"4","author":"Shenoy","year":"2013","journal-title":"Ther Adv Hematol"},{"issue":"1","key":"10.1016\/j.transci.2023.103719_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/asheducation-2016.1.625","article-title":"Sickle cell disease: when and how to transfuse","volume":"2016","author":"Howard","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"7","key":"10.1016\/j.transci.2023.103719_bib14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2174\/156652408786241438","article-title":"Current status in iron chelation in hemoglobinopathies","volume":"8","author":"Cappellini","year":"2008","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.transci.2023.103719_bib15","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jpeds.2006.06.037","article-title":"Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia","volume":"149","author":"Hulbert","year":"2006","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.transci.2023.103719_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/bjh.13294","article-title":"A comparison of chronic manual and automated red blood cell exchange transfusion in sickle cell disease patients","volume":"170","author":"Kuo","year":"2015","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.transci.2023.103719_bib17","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/trf.13558","article-title":"Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients","volume":"56","author":"Fasano","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2023.103719_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/088307380001500511","article-title":"Lessons from the stroke prevention trial in sickle cell anemia (STOP) study","volume":"15","author":"Adams","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.transci.2023.103719_bib19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/MPH.0b013e318279caae","article-title":"The other side of abnormal: a case series of low transcranial Doppler velocities associated with stroke in children with sickle cell disease","volume":"35","author":"Buchanan","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"issue":"14","key":"10.1016\/j.transci.2023.103719_bib20","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.110.007641","article-title":"On T2* magnetic resonance and cardiac iron","volume":"123","author":"Carpenter","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.transci.2023.103719_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1532-429X-16-40","article-title":"Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentra tion and comparison with R2 Ferriscan","volume":"16","author":"Garbowski","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.transci.2023.103719_bib22","first-page":"9","article-title":"Albuminuria is associated with endothelial dysfunction and elevated plasma endothelin-1 in sickle cell","volume":"11","author":"Ataga","year":"2016","journal-title":"Anemia"},{"key":"10.1016\/j.transci.2023.103719_bib23","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1182\/blood.V79.7.1657.1657","article-title":"A modified transfusion program for prevention of stroke in sickle cell disease","volume":"79","author":"Cohen","year":"1992","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.transci.2023.103719_bib24","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2013-12-545186","article-title":"SWiTCH Investigators. Magnetic resonance imaging\/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial","volume":"124","author":"Helton","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.transci.2023.103719_bib25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/bjh.13525","article-title":"Silent cerebral infarcts in very young children with sickle cell anaemia are associated with a higher risk of stroke","volume":"171","author":"Cancio","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2023.103719_bib26","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood-2010-06-293514","article-title":"Impact of intracranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in newborn sickle cell anemia cohort","volume":"117","author":"Bernaudin","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.transci.2023.103719_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jamaneurol.2013.576","article-title":"Acute silent cerebral ischemic events in children with sickle cell anemia","volume":"70","author":"Quinn","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.transci.2023.103719_bib28","first-page":"358","article-title":"Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the cooperative study of sickle cell disease","volume":"193","author":"Miller","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.transci.2023.103719_bib29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/jpepsy\/27.8.739","article-title":"Cognitive functioning in children with sickle cell disease: a meta-analysis","volume":"27","author":"Schatz","year":"2002","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.transci.2023.103719_bib30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00004703-200410000-00001","article-title":"Interactions of biomedical and environmental risk factors for cognitive development: a preliminary study of sickle cell disease","volume":"25","author":"Schatz","year":"2004","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.transci.2023.103719_bib31","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1182\/blood-2003-06-1972","article-title":"Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study","volume":"103","author":"Abboud","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.transci.2023.103719_bib32","first-page":"1793","article-title":"White matter damage relates to oxygen saturation in children with sickle cell anemia with silent cerebral infarction","volume":"46","author":"Kawadler","year":"2015","journal-title":"Br J Hematol"},{"issue":"3\u20134","key":"10.1016\/j.transci.2023.103719_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000373917","article-title":"Cerebral lesion on 7 tesla MRI in patient with sickle cell anemia","volume":"39","author":"Van der land","year":"2015","journal-title":"Cereb Dis"},{"issue":"2","key":"10.1016\/j.transci.2023.103719_bib34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/STR.0b013e3181fcb238","article-title":"Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Goldstein","year":"2011","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.transci.2023.103719_bib35","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/bmt.2011.245","article-title":"Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'","volume":"47","author":"Freed","year":"2012","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"10.1016\/j.transci.2023.103719_bib36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MPH.0000000000000327","article-title":"Cultural preferences and limited public resources influence the spectrum of thalassemia in Egypt","volume":"37","author":"Adly","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.transci.2023.103719_bib37","doi-asserted-by":"crossref","unstructured":"Staley EM, Pham HP. chapter Therapeutic Erythrocytapheresis and Red Cell Exchange in Transfusion Medicine and Hemostasis (Third Edition); 2019.","DOI":"10.1016\/B978-0-12-813726-0.00076-3"},{"key":"10.1016\/j.transci.2023.103719_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anaemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2023.103719_bib39","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1056\/NEJMoa050460","article-title":"Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease","volume":"353","author":"Adams","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2023.103719_bib40","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2011-11-392340","article-title":"Stroke with transfusions changing to hydroxyurea (SWiTCH)","volume":"119","author":"Ware","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.transci.2023.103719_bib41","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3476(95)70204-0","article-title":"Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions","volume":"126","author":"Pegelow","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.transci.2023.103719_bib42","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ajh.23105","article-title":"Chronic transfusion practices for prevention of primary stroke in children with sickle cell anemia and abnormal TCD velocities","volume":"87","author":"Aygun","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.transci.2023.103719_bib43","unstructured":"World Health Organization (WHO). WHO director-general\u2019s statement on IHR Emergency Committee on Novel Coronavirus (2019-nCoV); 2020. Available at www.who.int\/dg\/speeches\/detail\/ [Accessed 3 March 2020]."}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050223000939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050223000939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:54:36Z","timestamp":1761468876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050223000939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1473050223000939"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2023.103719","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The implementation of automated red blood cell exchange (erythrocytapheresis) as a treatment modality in sickle cell disease patients: Single center experience","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2023.103719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103719"}}